How to Cite
1.
Naafs B. Clinical aspects of the reversal reaction. Hansen. Int. [Internet]. 1998 Jun. 30 [cited 2024 Nov. 23];23(Especial):72-8. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35929
Abstract
.
References
1. NAAFS B. Reaction in leprosy. In: Biology of the Mycobacteria vol. 3 (Ratledge G,Stanford JL and Grange JM eds.) Academic Press (1989) 359-403
2. NAAFS B. Treatment of reactions and nerve damage. Int. J. Lepr. 64 (1996) S21-28
3. SUGAMARAM D.S.T. Steroid therapy for paralytic deformities in leprosy, Int. J. Lepr. 65 (1997) 337-344
4. GOODWIN C.S., The use of the voluntary muscle test in leprosy neuritis. Lepr. Rev. 39 (1968) 209-220
5. NAAFS B. and Dagne T. Sensory Testing. A' sensitive method in the follow-up of nerve involvement. Int. J. Lepr. 45 (1977) 364-368
6. MUNTE K., Pompe J.C. and Naafs B. Two point discrimination versus Semmes-Weinstein filaments in patients with hypostatic syndrome of the lower extremities. Submitted for publication.
7. WILDER-SMITH A. and Wilder Smith E. Effect of steroid therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis. Int. J. Lepr. 65 (1997) 20-27
8. ROCH P.W., Theuvenet WJ and Britton WJ. Risk factors for type I reactions in borderline leprosy patients. Lancet 338 (1991) 654-656
9. Parida S.K., Grau G.E., Zaheer S.A. and Mukherjee R. Serum Tumor Necrosis Factor and Interleukin1 in leprosy and during lepra reactions. Clin. Immunol. and lmmunopathol. 61 (1992) 23-27
10. VAN BRAKEL W.H., Khawas and Lucas S.B. Reactions in leprosy: an epidermiological study of 386 patients in West Nepal. Lepr. Rev. 65 (1994) 190-203
11. HAMERLINCK F., Faber W.R., Bordewijk L and Bos JD. Serum neopterin levels in patients with different types of leprosy. Quad. Coop. Sant (Health Cooperation Papers) 12 (1992) 105-106
12. VERHAGEN C.E., Faber W.R., Klatser P.R., Buffing A.A.M., Naafs B. and Das P.K. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Submitted for publication.
13. NAAFS B., Lyons N.F., Matemera B.O. and Madombi L. The Ellis and Ryde tests. Lepr. Rev. 58 (1987) 53-60
2. NAAFS B. Treatment of reactions and nerve damage. Int. J. Lepr. 64 (1996) S21-28
3. SUGAMARAM D.S.T. Steroid therapy for paralytic deformities in leprosy, Int. J. Lepr. 65 (1997) 337-344
4. GOODWIN C.S., The use of the voluntary muscle test in leprosy neuritis. Lepr. Rev. 39 (1968) 209-220
5. NAAFS B. and Dagne T. Sensory Testing. A' sensitive method in the follow-up of nerve involvement. Int. J. Lepr. 45 (1977) 364-368
6. MUNTE K., Pompe J.C. and Naafs B. Two point discrimination versus Semmes-Weinstein filaments in patients with hypostatic syndrome of the lower extremities. Submitted for publication.
7. WILDER-SMITH A. and Wilder Smith E. Effect of steroid therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis. Int. J. Lepr. 65 (1997) 20-27
8. ROCH P.W., Theuvenet WJ and Britton WJ. Risk factors for type I reactions in borderline leprosy patients. Lancet 338 (1991) 654-656
9. Parida S.K., Grau G.E., Zaheer S.A. and Mukherjee R. Serum Tumor Necrosis Factor and Interleukin1 in leprosy and during lepra reactions. Clin. Immunol. and lmmunopathol. 61 (1992) 23-27
10. VAN BRAKEL W.H., Khawas and Lucas S.B. Reactions in leprosy: an epidermiological study of 386 patients in West Nepal. Lepr. Rev. 65 (1994) 190-203
11. HAMERLINCK F., Faber W.R., Bordewijk L and Bos JD. Serum neopterin levels in patients with different types of leprosy. Quad. Coop. Sant (Health Cooperation Papers) 12 (1992) 105-106
12. VERHAGEN C.E., Faber W.R., Klatser P.R., Buffing A.A.M., Naafs B. and Das P.K. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Submitted for publication.
13. NAAFS B., Lyons N.F., Matemera B.O. and Madombi L. The Ellis and Ryde tests. Lepr. Rev. 58 (1987) 53-60
This journal is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
Download data is not yet available.
